Reported about 6 hours ago
Mitsubishi Chemical Group has selected Bain Capital as the preferred bidder for its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, with a potential sale valued at over 500 billion yen ($3.2 billion), according to a report by Nikkei. The deal follows a competitive bidding process that included firms like Blackstone.
Source: YAHOO